Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 286
  • Home
  • Print this page
  • Email this page
CASE REPORT
Year : 2016  |  Volume : 3  |  Issue : 2  |  Page : 182-184

Leukocytosis associated with clozapine in elderly patient


Department of Psychiatry, Mental Health Hospital, Taif 21944, Saudi Arabia

Correspondence Address:
Javed Ather Siddiqui
Mental Health Hospital, P. O. Box: 2056, Taif 21944
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2348-9995.195685

Rights and Permissions

Clozapine is the second-generation antipsychotic which is approved by the US Food and Drug Administration for the treatment of refractory schizophrenia. Clozapine is unfortunately associated with number of adverse effects, one of the chief concerns is agranulocytosis and occasionally leukocytosis, i.e. elevation of white blood cell count. In some cases, the leukocytosis may be persistent. We report the case of a 65-year-old patient diagnosed with schizophrenia, who also fulfilled the criteria of treatment-resistant schizophrenia, treated with clozapine as patient experienced leukocytosis.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed8042    
    Printed275    
    Emailed0    
    PDF Downloaded1046    
    Comments [Add]    

Recommend this journal